Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Li J.,,TCPA: A resource for cancer functional proteomics data,2013,Nature Methods,193,10.1038/nmeth.2650,United States,Letter,Houston,1,Journal,2-s2.0-84887083535
Hofree M.,,Network-based stratification of tumor mutations,2013,Nature Methods,415,10.1038/nmeth.2651,United States,Article,San Diego,1,Journal,2-s2.0-84887084951
Ciriello G.,,Emerging landscape of oncogenic signatures across human cancers,2013,Nature Genetics,703,10.1038/ng.2762,United States,Article,New York,1,Journal,2-s2.0-84884997982
Zack T.I.,,Pan-cancer patterns of somatic copy number alteration,2013,Nature Genetics,859,10.1038/ng.2760,United States;United States;United States,Article,Boston;Cambridge;Cambridge,1,Journal,2-s2.0-84885008220
Wheeler D.,,From human genome to cancer genome: The first decade,2013,Genome Research,79,10.1101/gr.157602.113,United States,Review,Houston,1,Journal,2-s2.0-84880063629
Lawrence M.S.,,Mutational heterogeneity in cancer and the search for new cancer-associated genes,2013,Nature,2675,10.1038/nature12213,United States,Article,Cambridge,0,Journal,2-s2.0-84880507665
Baca S.C.,,Punctuated evolution of prostate cancer genomes,2013,Cell,668,10.1016/j.cell.2013.03.021,United States;United States;United States,Article,Cambridge;Boston;Boston,1,Journal,2-s2.0-84875757638
Vogelstein B.,,Cancer genome landscapes,2013,Science,3950,10.1126/science.1235122,United States,Review,Baltimore,1,Journal,2-s2.0-84875490185
Garraway L.,,Lessons from the cancer genome,2013,Cell,740,10.1016/j.cell.2013.03.002,United States;United States;United States,Review,Boston;Boston;Cambridge,1,Journal,2-s2.0-84875758730
Palles C.,,Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas,2013,Nature Genetics,554,10.1038/ng.2503,United Kingdom,Article,Oxford,0,Journal,2-s2.0-84873096362
Tamborero D.,,Comprehensive identification of mutational cancer driver genes across 12 tumor types,2013,Scientific Reports,292,10.1038/srep02650,Spain,Article,Barcelona,1,Journal,2-s2.0-84885129618
Alexandrov L.B.,,Signatures of mutational processes in human cancer,2013,Nature,4126,10.1038/nature12477,United Kingdom,Article,London,1,Journal,2-s2.0-84882837534
Muzny D.M.,,Comprehensive molecular characterization of human colon and rectal cancer,2012,Nature,4331,10.1038/nature11252,United States,Article,Houston,1,Journal,2-s2.0-84863922124
Weinstein J.,,Drug discovery: Cell lines battle cancer,2012,Nature,46,10.1038/483544a,United States,Short Survey,Houston,0,Journal,2-s2.0-84859206122
Garnett M.J.,,Systematic identification of genomic markers of drug sensitivity in cancer cells,2012,Nature,1347,10.1038/nature11005,United Kingdom,Article,Hinxton,0,Journal,2-s2.0-84859187259
Barretina J.,,The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity,2012,Nature,3344,10.1038/nature11003,United States;United States;United States,Article,Cambridge;Boston;Cambridge,0,Journal,2-s2.0-84859169877
Takeuchi K.,,"RET, ROS1 and ALK fusions in lung cancer",2012,Nature Medicine,834,10.1038/nm.2658,Japan,Article,Tokyo,0,Journal,2-s2.0-84857985225
Heiser L.M.,,Subtype and pathway specific responses to anticancer compounds in breast cancer,2012,Proceedings of the National Academy of Sciences of the United States of America,278,10.1073/pnas.1018854108,United States,Article,Berkeley,1,Journal,2-s2.0-84863115693
Kostic A.,,Genomic analysis identifies association of Fusobacterium with colorectal carcinoma,2012,Genome Research,838,10.1101/gr.126573.111,United States;United States,Article,Cambridge;Boston,1,Journal,2-s2.0-84863022950
Wang N.J.,,Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma,2011,Proceedings of the National Academy of Sciences of the United States of America,266,10.1073/pnas.1114669108,United States,Article,Berkeley,1,Journal,2-s2.0-80055092549
Stransky N.,,The mutational landscape of head and neck squamous cell carcinoma,2011,Science,1512,10.1126/science.1208130,United States,Article,Cambridge,0,Journal,2-s2.0-80052158097
Chapman P.B.,,Improved survival with vemurafenib in melanoma with BRAF V600E mutation,2011,New England Journal of Medicine,5313,10.1056/NEJMoa1103782,United States,Article,New York,0,Journal,2-s2.0-79959795786
Hanahan D.,,Hallmarks of cancer: The next generation,2011,Cell,30122,10.1016/j.cell.2011.02.013,United States;Switzerland,Review,San Francisco;Epalinges,1,Journal,2-s2.0-79952284127
Stephens P.J.,,Massive genomic rearrangement acquired in a single catastrophic event during cancer development,2011,Cell,1324,10.1016/j.cell.2010.11.055,United Kingdom,Article,Hinxton,1,Journal,2-s2.0-78650959663
McDermott U.,,Personalized cancer therapy with selective kinase inhibitors: An emerging paradigm in medical oncology,2009,Journal of Clinical Oncology,103,10.1200/JCO.2009.22.9054,United States,Review,Boston,0,Journal,2-s2.0-73949087586
Mardis E.R.,,Recurring mutations found by sequencing an acute myeloid leukemia genome,2009,New England Journal of Medicine,1578,10.1056/NEJMoa0903840,United States,Article,St. Louis,0,Journal,2-s2.0-70149093912
Soda M.,,Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer,2007,Nature,3648,10.1038/nature05945,Japan,Article,Kawachi District,0,Journal,2-s2.0-34547638047
Tomlins S.,,Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer,2005,Science,2773,10.1126/science.1117679,United States,Article,Ann Arbor,0,Journal,2-s2.0-27344451557
Weng A.,,Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia,2004,Science,1948,10.1126/science.1102160,Canada;United States,Article,Vancouver;Boston,0,Journal,2-s2.0-5044225888
Paez J.G.,,"EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy",2004,Science,7753,10.1126/science.1099314,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-2342624080
Davies H.,,Mutations of the BRAF gene in human cancer,2002,Nature,7155,10.1038/nature00766,United Kingdom,Article,London,0,Journal,2-s2.0-18444374405
Perou C.,,Molecular portraits of human breast tumours,2000,Nature,10061,10.1038/35021093,United States,Article,Stanford,0,Journal,2-s2.0-0034680102
Hanahan D.,,The hallmarks of cancer,2000,Cell,19621,10.1016/S0092-8674(00)81683-9,United States,Review,San Francisco,1,Journal,2-s2.0-0034614637
Zagouras P.,,Alterations in Notch signaling in neoplastic lesions of the human cervix,1995,Proceedings of the National Academy of Sciences of the United States of America,330,10.1073/pnas.92.14.6414,United States,Article,New Haven,1,Journal,2-s2.0-0029078323
Baker S.,,Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas,1989,Science,1588,10.1126/science.2649981,United States,Article,Baltimore,0,Journal,2-s2.0-0024536654
Payne G.,,Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas,1982,Nature,304,10.1038/295209a0,United States,Article,San Francisco,0,Journal,2-s2.0-0020048733
Parada L.F.,,Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene,1982,Nature,552,10.1038/297474a0,United States,Article,Cambridge,0,Journal,2-s2.0-0020328955
